The Forward BIO Institute institute aims at making Wisconsin a Midwestern hub of the ongoing merger of pharmaceuticals, medical devices and cutting-edge tissue engineering.
UW-Madison scientists have shown that a recently-discovered variety of lignin, catechyl lignin (C-lignin), has attributes that could make it well-suited as the starting point for a range of bioproducts.
Often, in order to identify a fatty liver, an invasive liver biopsy is required. Taking a blood sample would be a much simpler way to diagnose it.
With countless tools and machines, the possibilities for bringing an idea to life are endless at the College of Engineering’s Technical…
Promising results in the lab and in animal models could set the stage for developing a treatment for Alexander disease, a rare and usually fatal neurological disease with no known cure.
Carl Ross has more than 26 years of experience advancing a wide range of cell and gene therapies, vaccines and therapeutic proteins into human clinical trials.
As you bite into your next peanut butter and jelly sandwich, chew on this: The peanut you’re eating has a secret.
Ophelia Venturelli's research may lead to the ability to engineer behaviors among beneficial microbes in the gut ecosystem, which could be used to enhance their resilience to invasion by pathogens or unintended impairment from antibiotics.